CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 4, 2019--
Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that Doug Treco,
Ph.D., President and Chief Executive Officer of Ra Pharma, will present
at the Cowen 39th Annual Health Care Conference on Monday,
March 11, 2019 at 1:30 p.m. E.T. The conference is being held at Boston
Marriott Copley Place, Boston, MA.
The presentation will be webcast live and can be accessed by visiting
the investor relations section of the Company’s website, www.rapharma.com.
A replay of the presentation will also be available and archived on the
site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the complement
cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190304005339/en/
Source: Ra Pharmaceuticals
Ra Pharmaceuticals, Inc.
David Rosen, 212-600-1902